國立高雄大學圖資館 |

Language: English

Back

Diabetes mellitusa risk factor for A...

Nakabeppu, Yusaku.

Diabetes mellitusa risk factor for Alzheimer's disease /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Diabetes mellitusedited by Yusaku Nakabeppu, Toshiharu Ninomiya.
Reminder of title:	a risk factor for Alzheimer's disease /
other author:	Nakabeppu, Yusaku.
Published:	Singapore :Springer Singapore :2019.
Description:	vi, 248 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Diabetes.
Online resource:	https://doi.org/10.1007/978-981-13-3540-2
ISBN:	9789811335402$q(electronic bk.)

Diabetes mellitusa risk factor for Alzheimer's disease /
Diabetes mellitusa risk factor for Alzheimer's disease /[electronic resource] :edited by Yusaku Nakabeppu, Toshiharu Ninomiya. - Singapore :Springer Singapore :2019. - vi, 248 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,11280065-2598 ;. - Advances in experimental medicine and biology ;946..

Chapter 1 Origins of brain insulin and its function -- Chapter 2 Epidemiological evidence of the relationship between diabetes and dementia -- Chapter 3 Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in Alzheimer's Disease Brain -- Chapter 4 The Full Spectrum of Alzheimer's Disease is Rooted in Metabolic -- Derangements That Drive Type 3 Diabetes -- Chapter 5 The roles of apolipoprotein E, lipids and glucose in the pathogenesis of Alzheimer's disease -- Chapter 6 Molecular connection between diabetes and dementia -- Chapter 7 Type II Diabetes mellitus accelerates age-dependent Ab pathology in cynomolgus monkey brain -- Chapter 8 Diabetes-related dementia -- Chapter 9 Tortuous paths of insulin signaling and mitochondria in Alzheimer's disease -- Chapter 10 Mammalian target of rapamycin at the crossroad between Alzheimer's Disease and diabetes -- Chapter 11 Therapeutic strategies for Alzheimer's disease in the view of diabetes mellitus.

This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer's disease (AD) It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore in depth the mechanisms involved in this relationship, including abnormal protein processing, dysregulated glucose metabolism, impaired insulin signaling, and mitochondrial dysfunction. The molecular interactions between diabetes and AD are fully discussed, highlighting the pathological molecular mechanisms induced by diabetes that promote and accelerate AD pathology. Finally, diagnostic biomarkers and potential therapeutic approaches for AD are considered on the basis of the presented evidence. In providing answers to the critical questions of whether and why DM is a risk factor for AD, this book will hold appeal for a wide interdisciplinary audience.

ISBN: 9789811335402$q(electronic bk.)

Standard No.: 10.1007/978-981-13-3540-2doiSubjects--Topical Terms:

274215
Diabetes.

LC Class. No.: RC660 / .D533 2019

Dewey Class. No.: 616.462

Diabetes mellitusa risk factor for Alzheimer's disease /
LDR:03258nmm a2200337 a 4500 001 558600
003 DE-He213
005 20191016154909.0
006 m d
007 cr nn 008maaau
008 191219s2019 si s 0 eng d
020 $a 9789811335402$q(electronic bk.)
020 $a 9789811335396$q(paper)
024 7 $a 10.1007/978-981-13-3540-2 $2 doi
035 $a 978-981-13-3540-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC660 $b .D533 2019
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 616.462 $2 23
090 $a RC660 $b .D536 2019
245 0 0 $a Diabetes mellitus $h [electronic resource] : $b a risk factor for Alzheimer's disease / $c edited by Yusaku Nakabeppu, Toshiharu Ninomiya.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a vi, 248 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v 1128
505 0 $a Chapter 1 Origins of brain insulin and its function -- Chapter 2 Epidemiological evidence of the relationship between diabetes and dementia -- Chapter 3 Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in Alzheimer's Disease Brain -- Chapter 4 The Full Spectrum of Alzheimer's Disease is Rooted in Metabolic -- Derangements That Drive Type 3 Diabetes -- Chapter 5 The roles of apolipoprotein E, lipids and glucose in the pathogenesis of Alzheimer's disease -- Chapter 6 Molecular connection between diabetes and dementia -- Chapter 7 Type II Diabetes mellitus accelerates age-dependent Ab pathology in cynomolgus monkey brain -- Chapter 8 Diabetes-related dementia -- Chapter 9 Tortuous paths of insulin signaling and mitochondria in Alzheimer's disease -- Chapter 10 Mammalian target of rapamycin at the crossroad between Alzheimer's Disease and diabetes -- Chapter 11 Therapeutic strategies for Alzheimer's disease in the view of diabetes mellitus.
520 $a This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer's disease (AD) It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore in depth the mechanisms involved in this relationship, including abnormal protein processing, dysregulated glucose metabolism, impaired insulin signaling, and mitochondrial dysfunction. The molecular interactions between diabetes and AD are fully discussed, highlighting the pathological molecular mechanisms induced by diabetes that promote and accelerate AD pathology. Finally, diagnostic biomarkers and potential therapeutic approaches for AD are considered on the basis of the presented evidence. In providing answers to the critical questions of whether and why DM is a risk factor for AD, this book will hold appeal for a wide interdisciplinary audience.
650 0 $a Diabetes. $3 274215
650 0 $a Alzheimer's disease $x Risk factors. $3 841305
650 1 4 $a Neurosciences. $3 211508
650 2 4 $a Neurology. $3 211583
700 1 $a Nakabeppu, Yusaku. $3 841303
700 1 $a Ninomiya, Toshiharu. $3 841304
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-981-13-3540-2
950 $a Biomedical and Life Sciences (Springer-11642)